Skip to main content
. 2020 Feb 6;8(1):e000363. doi: 10.1136/jitc-2019-000363

Figure 1.

Figure 1

Recent development of high-dimensional immune profiling technologies. Transition of immunoprofiling technologies from conventional tools in the past, to cutting-edge, high-dimensional technologies in the present which have overcome previous limitations and are equipped with enhanced capabilities for a deeper understanding of the complex and heterogeneous tumor microenvironment as well as for the identification of potential biomarkers for immunotherapy. ATAC, assay for transposase-accessible chromatin; Seq, sequencing; sc, single-cell.